Related Experiment Video
Updated: Aug 30, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Absence of mutations in major GEFS+ genes in myoclonic astatic epilepsy
R Nabbout1, A Kozlovski, E Gennaro
1Département de Neuropédiatrie, Hôpital Saint Vincent-de-Paul, AP-HP, 82 Avenue Denfert Rochereau, 75014 Paris, France. rimanabbout@yahoo.com
Abstract:
Myoclonic astatic epilepsy (MAE) is a genetically determined condition of childhood onset characterized by multiple generalized types of seizures including myoclonic astatic seizures, generalized spike waves and cognitive deterioration. This condition has been reported in a few patients in generalized epilepsy with febrile seizures plus (GEFS+) families and MAE has been considered, like severe myoclonic epilepsy of infancy (SMEI), to be a severe phenotype within the GEFS+ spectrum. Four genes have been identified in GEFS+ families, but only three (SCN1A, SCNlB, GABRG2) were found in MAE patients within GEFS+ families. We analysed these three genes in a series of 22 sporadic patients with MAE and found no causal mutations. These findings suggest that MAE, unlike SMEI, is not genetically related to GEFS+. Although MAE and SMEI share the same types of seizures, only SMEI patients are sensitive to fever. This is probably its main link to GEFS+. A different family of genes is likely to account for MAE.
Insights
Myoclonic astatic epilepsy (MAE) is not genetically linked to GEFS+ spectrum disorders. Genetic analysis of known GEFS+ genes in MAE patients revealed no causal mutations, suggesting different genetic factors for MAE.
Area of Science:
- Epilepsy genetics
- Pediatric neurology
- Clinical genetics
Background:
- Myoclonic astatic epilepsy (MAE) is a childhood-onset epilepsy with generalized seizures and cognitive decline.
- MAE has been considered a severe phenotype within the Generalized Epilepsy with Febrile Seizures Plus (GEFS+) spectrum.
- Severe myoclonic epilepsy of infancy (SMEI) shares seizure types with MAE and is linked to GEFS+.
Purpose of the Study:
- To investigate the genetic relationship between Myoclonic Astatic Epilepsy (MAE) and Generalized Epilepsy with Febrile Seizures Plus (GEFS+).
- To identify potential causal mutations in genes previously associated with GEFS+ families within sporadic MAE patients.
Main Methods:
- Analysis of three known GEFS+-associated genes (SCN1A, SCN1B, GABRG2).
- Genetic screening was performed on a cohort of 22 sporadic patients diagnosed with MAE.
Main Results:
- No causal mutations were identified in the analyzed SCN1A, SCN1B, and GABRG2 genes in the 22 sporadic MAE patients.
- These findings indicate that MAE is unlikely to be genetically related to GEFS+.
- Unlike SMEI, MAE patients do not exhibit fever sensitivity, a key characteristic linking SMEI to GEFS+.
Conclusions:
- Myoclonic astatic epilepsy (MAE) appears genetically distinct from the GEFS+ spectrum.
- The genetic underpinnings of MAE likely involve a different set of genes than those identified in GEFS+.
- Further research is needed to elucidate the genetic etiology of MAE.
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types
Seizures ll: Types
Mutations
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

